PRESS RELEASE published on 12/04/2025 at 18:53, 7 months 4 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Outlook for fiscal year 2026 and update of mid-term guidance SCHOTT Pharma AG & Co. KGaA issues fiscal year 2026 outlook and updates mid-term guidance, projecting revenue growth of 2-5% and EBITDA margin around 27%. Market expectations differ Revenue Growth Financial Guidance EBITDA Margin SCHOTT Pharma Fiscal Year 2026
BRIEF published on 11/05/2025 at 18:24, 8 months 3 days ago Transition de direction chez SCHOTT Pharma : Christian Mias nommé PDG SCHOTT Pharma Croissance Pharmaceutique Nomination Exécutive Transition Du Leadership Christian Mias
BRIEF published on 11/05/2025 at 18:24, 8 months 3 days ago Leadership Transition at SCHOTT Pharma: Christian Mias Appointed CEO SCHOTT Pharma Leadership Transition Executive Appointment Pharmaceutical Growth Christian Mias
PRESS RELEASE published on 11/05/2025 at 18:19, 8 months 3 days ago SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Christian Mias appointed as CEO of SCHOTT Pharma, succeeding Andreas Reisse. Strategic leadership transition ensured for global pharmaceutical packaging leader Pharmaceutical SCHOTT Pharma CEO Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 8 months 3 days ago Christian Mias nommé nouveau PDG de SCHOTT Pharma SCHOTT Pharma Nomination Du PDG Changement De Leadership Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 8 months 3 days ago Christian Mias Appointed as New CEO of SCHOTT Pharma CEO Appointment SCHOTT Pharma Leadership Change Christian Mias Andreas Reisse
PRESS RELEASE published on 11/05/2025 at 17:56, 8 months 3 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO SCHOTT Pharma AG & Co. KGaA appoints Christian Mias as CEO to succeed Andreas Reisse, effective May 1, 2026. Inside information disclosed. Press release via EQS News Inside Information CEO Appointment SCHOTT Pharma EQS News Christian Mias
BRIEF published on 08/12/2025 at 07:05, 10 months 27 days ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
BRIEF published on 08/12/2025 at 07:05, 10 months 27 days ago SCHOTT Pharma annonce des résultats stables au troisième trimestre 2025 Innovation SCHOTT Pharma Solutions À Haute Valeur Ajoutée Confinement Des Drogues Résultats Du Troisième Trimestre 2025
PRESS RELEASE published on 08/12/2025 at 07:00, 10 months 27 days ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
Published on 07/08/2026 at 15:25, 6 hours 49 minutes ago Rockhaven Announces Granting of Incentive Stock Options
Published on 07/08/2026 at 15:00, 7 hours 14 minutes ago Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Published on 07/08/2026 at 15:00, 7 hours 14 minutes ago GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Published on 07/08/2026 at 14:30, 7 hours 44 minutes ago Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily
Published on 07/08/2026 at 21:00, 1 hour 13 minutes ago Legendary Entertainment and Warner Bros. Pictures Unveil Dune: Part Three Trailer and Behind-the-Scenes Images Showcasing Abu Dhabi as Arrakis
Published on 07/08/2026 at 19:42, 2 hours 31 minutes ago EQS-Adhoc: SMAG Mobile Antenna Masts AG sets final offer price for initial public offering (IPO) at EUR 46 per share
Published on 07/08/2026 at 18:52, 3 hours 21 minutes ago namR: PRONONCÉ DE LA LIQUIDATION JUDICIAIRE DE LA SOCIÉTÉ SA NAM.R
Published on 07/08/2026 at 18:45, 3 hours 28 minutes ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
Published on 07/08/2026 at 20:00, 2 hours 14 minutes ago ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 07/08/2026 at 20:00, 2 hours 14 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 07/08/2026 at 20:00, 2 hours 14 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JUIN 2026
Published on 07/08/2026 at 20:00, 2 hours 14 minutes ago ALTAREA - DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JUIN 2026
Published on 07/08/2026 at 20:00, 2 hours 14 minutes ago ALTAREIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
